Back
IMM
Description
Description
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. The company is headquartered in Sydney, New South Wales. The firm is focused on developing novel immunotherapies for cancer and autoimmune disease. The company is focused on advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3’s ability to stimulate or suppress the immune response. Its lead clinical c...
Show more
ASX
Biotechnology
Socially Aware
Performance
Performance
$0.40
AUD
▼ -$0.03 (-5.95%)
19th February 2026, 05:42 a.m.
1M
1Y
10Y
GRAPH
TABLE
GRAPH
TABLE
Quick facts
Quick facts
▼ -0.25% Growth
5 year average annual growth
N/A
5 year average dividend yield
$500 minimum investment
Due to regulatory requirements
$1,180.26 median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
ESG
ESG
53.25
Environmental score
99
Social score
15.98
Governance score
Community insights
Community insights
General statistics
17 investors hold IMM
26 weeks average time between investments
$3,883 average holding per investor
35 days since last community investment
Demographics
Income of investors
Less than 50k
47%
50k - 100k
16%
150k - 200k
16%
100k - 150k
11%
More than 200k
11%
Age of investors
35-90 years old
71%
26-34 years old
24%
18-25 years old
6%
Legal gender of investors
59% male
41% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Fri Feb 20 2026, and may have changed since.
Learn more
Learn more
November Investing Q&A with Strong Money Australia
READ
Financial Independence
In the immortal and slightly rephrased words of Montell Jordan: "This is Gow we do it". And by "it", we mean "a much-lov...
28 October 2024
・
Dave Gow
・
8 min read
0 likes
・
6 views
Invest with an immigrant Bondi tradie turned business owner feat. Raul Engel | Get Rich Slow Club
READ
Financial Independence
Long Term Investing
In this Get Rich Slow Club episode, Tash and Ana chat with entrepreneur, investor, and Portuguese language financial edu...
26 July 2023
・
Tash & Ana
・
5 min read
0 likes
・
1 view
Episode 17. Invest with an immigrant Bondi tradie turned business owner feat. Raul Engel
LISTEN
From the first episode, the Get Rich Slow Club has sought to champion one key concept: investing isn’t only for rich whi...
Mon, 24th July 2023
・
42 min
・
0 likes
Episode 105. We spent the week with 50 people planning to retire early
LISTEN
The term “Financial Independence Retire Early” is bandied around a lot in the investing community. But how do you reach ...
Wed, 30th October 2024
・
32 min
・
0 likes
The Aussie FIRE Audiobook | Conclusion
LISTEN
Congratulations! You've made it to the final chapter of our original Aussie FIRE audiobook. In each chapter, we've cover...
Fri, 3rd November 2023
・
8 min
・
0 likes
Episode 0. Welcome to the Aussie FIRE podcast
LISTEN
Welcome to Aussie FIRE, the podcast designed to educate and inspire you towards a better future! This podcast evolved fr...
Fri, 24th November 2023
・
30 min
・
3 likes
US ETFs vs AU ETFs
ASK & ANSWER
Investing Strategy
Are there any downsides to choosing US ETFs over AU ones? Some of the US ETFs outperform AU ones, but as an Australian c...
Stephanie Conroy
•
April 3rd, 2024
0 likes
・
409 views
・
AU vs US shares
ASK & ANSWER
First Time Investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
5 likes
・
218 views
・
What’s happened to my shares and it’s value if I suddenly die
ASK & ANSWER
Investing Strategy
Hi, I just started my investment with ASX last month. But I started worrying and wanted to know what’s happened to my sh...
Ngoc Nguyen
•
September 30th, 2022
3 likes
・
320 views
・